Know Your Team

Fixed duration therapy vs. continuous duration therapy for CLL patients
Why is it important for a myeloma patient to be aware of the symptoms of amyloidosis?
How can I prepare for the end of treatment, both emotionally and practically?
When and why should I bring up side effects with my doctor?
Why does the list of chromosomal abnormalities that are consider high risk change or evolve over time?
What are the International Myeloma Working Group's consensus imaging guidelines for myeloma?
Is there a higher prevalence of amyloidosis in African Americans?
Why is it important for a patient to know the cytogenetic abnormalities of their myeloma?
What other supportive therapies may I be receiving in addition to the CLL treatment?